Michael T. Cullen
2021
In 2021, Michael T. Cullen earned a total compensation of $555.3K as Former Executive Chairman at Panbela Therapeutics, a 9% decrease compared to previous year.
Compensation breakdown
| Option Awards | $200,201 |
|---|---|
| Salary | $337,147 |
| Stock Awards | $17,998 |
| Total | $555,346 |
Cullen received $337.1K in salary, accounting for 61% of the total pay in 2021.
Cullen also received $200.2K in option awards and $18K in stock awards.
Rankings
In 2021, Michael T. Cullen's compensation ranked 10,492nd out of 12,415 executives tracked by ExecPay. In other words, Cullen earned more than 15.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,492 out of 12,415 | 16th |
Division Manufacturing | 4,646 out of 5,505 | 16th |
Major group Chemicals And Allied Products | 2,084 out of 2,375 | 12th |
Industry group Drugs | 1,848 out of 2,096 | 12th |
Industry Pharmaceutical Preparations | 1,371 out of 1,546 | 11th |
Source: SEC filing on April 29, 2022.
Cullen's colleagues
We found two more compensation records of executives who worked with Michael T. Cullen at Panbela Therapeutics in 2021.